Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Siegeskaurolic acid exhibits anti-inflammatory and antinociceptive effects, which due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation.
Description | Siegeskaurolic acid exhibits anti-inflammatory and antinociceptive effects, which due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation. |
Molecular Weight | 320.47 |
Formula | C20H32O3 |
CAS No. | 52645-97-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Siegeskaurolic acid 52645-97-3 G蛋白偶联受体 NF-Kb信号通路 凋亡 免疫与炎症 神经科学 Prostaglandin Receptor TNF COX NOS NF-κB Inhibitor inhibitor inhibit